DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
National Institute for Health and Care Excellence (NICE).
Final appraisal determination – Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism.
2013 [cited September 1, 2015]; Available at:
https://www.nice.org.uk/guidance/TA287/documents/pulmonary-embolism-acute-treatment-vte-prevention-rivaroxaban-final-appraisal-determination-document2 . Accessed August 30, 2018
We do not assume any responsibility for the contents of the web pages of other providers.